Literature DB >> 15754019

Plasma level and tissue expression of angiogenic factors in patients with hereditary hemorrhagic telangiectasia.

Haneen Sadick1, Ramin Naim, Maliha Sadick, Karl Hörmann, Frank Riedel.   

Abstract

The value of angiogenic factors interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF) was determined in patients with hereditary hemorrhagic telangiectasia (HHT) to evaluate their role in HHT pathogenesis. IL-8 and VEGF were measured in plasma of 41 HHT patients and healthy controls by ELISA technique. In both groups, the IL-8 and VEGF tissue expression in cryostat sections of the nasal mucosa were then compared. VEGF plasma levels were significantly increased in HHT patients compared to healthy controls. In contrast, the IL-8 plasma levels in both groups did not show any significant difference. Compared to healthy controls, HHT tissue samples showed a weak IL-8 staining, whereas the VEGF staining was very strong. The plasma levels of VEGF and IL-8 could not be correlated to the patients' clinicopathological findings. Additionally to the angiogenic pro-inflammatory cytokine IL-8, the angiogenic factor VEGF seems to play a major role in HHT pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754019

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

1.  Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.

Authors:  Y H Kim; M-J Kim; S-W Choe; D Sprecher; Y J Lee; S P Oh
Journal:  J Thromb Haemost       Date:  2017-05-03       Impact factor: 5.824

2.  Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

Authors:  Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

Review 3.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

4.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.

Authors:  Sung Ok Park; Mamta Wankhede; Young Jae Lee; Eun-Jung Choi; Naime Fliess; Se-Woon Choe; Seh-Hoon Oh; Glenn Walter; Mohan K Raizada; Brian S Sorg; S Paul Oh
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

5.  Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension.

Authors:  Luigi F Bertoli; Pauline L Lee; Lauren Lallone; James C Barton
Journal:  Case Rep Gastroenterol       Date:  2017-05-17

6.  The roles of endoglin gene in cerebrovascular diseases.

Authors:  Wan Zhu; Li Ma; Rui Zhang; Hua Su
Journal:  Neuroimmunol Neuroinflamm       Date:  2017-10-17

7.  Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.

Authors:  Marie E Faughnan; James R Gossage; Murali M Chakinala; S Paul Oh; Raj Kasthuri; Christopher C W Hughes; Justin P McWilliams; Joseph G Parambil; Nicholas Vozoris; Jill Donaldson; Gitanjali Paul; Pamela Berry; Dennis L Sprecher
Journal:  Angiogenesis       Date:  2018-09-06       Impact factor: 9.596

Review 8.  Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia.

Authors:  Carmelo Bernabeu; Pinar Bayrak-Toydemir; Jamie McDonald; Michelle Letarte
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

9.  Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation.

Authors:  Rachel Muster; Nerissa Ko; Wade Smith; Hua Su; Melissa A Dickey; Jeffrey Nelson; Charles E McCulloch; Patricia K Sneed; Jennifer L Clarke; David A Saloner; Laura Eisenmenger; Helen Kim; Daniel L Cooke
Journal:  BMJ Neurol Open       Date:  2021-03-17

10.  Argon plasma coagulation is not effective in every vascular lesion.

Authors:  Himadri Chauhan; Sherly Mathews; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.